“Dimethyl Itaconate As A Novel Anti-Inflammatory Agent Targeting Tnf-Α-Driven Nf-Κb Activation In Epithelial Cell Models”. 2025. The Review of Diabetic Studies, September, 1-21. https://doi.org/10.1900/q356v768.